Related Experiment Videos
O-GlcNAcylation: A bridge for regulating the function of the "heart-kidney-bone axis"
Shuangcui Wang1, Maojuan Guo2, Bo Yang3
1Department of Orthopedic Surgery, Hebei Medical University Third Hospital, Shijiazhuang, Hebei, China.
Insights
O-linked N-acetylglucosamine (O-GlcNAc) glycosylation is a key regulator of the heart-kidney-bone axis. Understanding O-GlcNAcylation
Area of Science:
- Biochemistry
- Physiology
- Pathology
Background:
- The heart, kidney, and bone systems are interconnected, forming the "heart-kidney-bone axis."
- Cardiorenal syndrome, renal bone disease, and cardiovascular calcification in CKD-MBD exemplify axis dysfunction.
- The underlying molecular mechanisms regulating this axis remain incompletely understood.
Purpose of the Study:
- To systematically review the role of O-linked N-acetylglucosamine (O-GlcNAc) glycosylation in the heart, kidney, and skeletal systems.
- To explore the cross-organ regulatory mechanisms of O-GlcNAcylation within the "heart-kidney-bone axis."
- To provide novel insights for mechanism analysis and targeted therapies for related comorbidities.
Main Methods:
- Literature review focusing on O-GlcNAcylation.
- Analysis of O-GlcNAc's role in cardiovascular, renal, and bone physiology and pathology.
- Examination of the hexosamine biosynthesis pathway (HBP) and its integration of nutritional and stress signals.
Main Results:
- O-GlcNAcylation is a dynamic post-translational modification integrating cellular signals.
- This modification is extensively involved in regulating cellular functions crucial to heart, kidney, and bone health.
- O-GlcNAcylation plays a significant role in the progression of diseases affecting these organs.
Conclusions:
- O-GlcNAcylation is a critical molecular player in the "heart-kidney-bone axis."
- Understanding its regulatory network offers new avenues for therapeutic interventions.
- Targeting O-GlcNAcylation may provide novel strategies for managing complex comorbidities.
Abstract:
The three major organ systems of heart, kidney and bone are highly correlated in physiology and pathology. They form the "heart-kidney-bone axis" together. The typical clinical manifestations of this axis include the deterioration of heart and kidney function, reflected by cardiorenal syndrome, renal bone disease, and cardiovascular calcification contained in chronic kidney disease-mineral bone disorder (CKD-MBD). However, the core molecular mechanism that regulates this axis has not been fully understood. O-linked N-acetylglucosamine (O-GlcNAc) glycosylation modification is a dynamic, reversible and highly conserved protein post-translational modification (PTM). It integrates body nutrition and stress signals via the hexosamine biosynthesis pathway (HBP), extensively participates in fine cellular function regulation, and plays an essential role in the progression of heart, kidney and bone diseases. This review systematically summarizes the role and multidimensional regulatory network characteristics of O-GlcNAcylation in heart, kidney and skeletal systems. It focuses on exploring its cross-organ regulatory mechanism in the "heart-kidney-bone axis", and aims to provide new ideas for the mechanism analysis and targeted therapy of comorbidities.
Related Concept Videos
cAMP-dependent Protein Kinase Pathways
GPCRs Regulate Adenylyl Cylase Activity
Two...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Endocrine Signaling
Proteoglycans
Protein Glycosylation
Glycosylation occurs in...